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Abstract  17 
Debate regarding the co-existence of Staphylococcus aureus and Pseudomonas 18 
aeruginosa in wounds remains contentious, with the dominant hypothesis describing 19 
a situation akin to niche partitioning, whereby both microorganisms are present but 20 
occupy distinct regions of the wound without interacting.  In contrast, we 21 
hypothesised that these microorganisms do interact during early co-colonisation in a 22 
manner beneficial to both bacteria.  We assessed competitive interaction between S. 23 
aureus and P. aeruginosa in biofilm cultured for 24-72 h and bacterial aggregates 24 
analogous to those observed in early (<24h) biofilm formation, and interaction with 25 
human keratinocytes.  We observed that S. aureus predominated in biofilm and non-26 
attached bacterial aggregates, acting as a pioneer for the attachment of P. 27 
aeruginosa.  We report for the first time that S. aureus mediates a significant 28 
(P<0.05) increase in the attachment of P. aeruginosa to human keratinocytes, and 29 
that P. aeruginosa promotes an invasive phenotype in S. aureus.  We show that co-30 
infected keratinocytes exhibit an intermediate inflammatory response concurrent with 31 
impaired wound closure that is in keeping with a sustained pro-inflammatory 32 
response which allows for persistent microbial colonisation.  These studies 33 
demonstrate that, contrary to the dominant hypothesis, interactions between S. 34 
aureus and P. aeruginosa may be an important factor for both colonisation and 35 
pathogenicity in the chronic infected wound. 36 
  37 
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Introduction  38 
 39 
The prevention and management of biofilm in wounds is a priority for clinicians and 40 
researchers, and is allied with the increased global focus on antimicrobial 41 
stewardship due to the increasing number of multi-drug resistant bacteria (Mashburn 42 
et al., 2005; Tümmler et al., 2014; Barnabie et al., 2015; WUWHS, 2016). Biofilms 43 
are thought to be present in most wounds and are known to be comprised of multiple 44 
bacterial species; moreover, their incidence is documented as having a deleterious 45 
impact on wound healing. 46 
There are a number of different guidelines supporting the diagnosis and 47 
treatment of biofilms in wounds, but detecting biofilm is challenging in clinical 48 
practice (Dohmen et al., 2008; Rhoads et al., 2008; Hoiby et al., 2010; Gottrup et al., 49 
2011; Metcalfe et al., 2016; WUWHS, 2016). Most guidelines are predicated on 50 
expert opinion, yet in reality little is known about the impact of bacterial interaction on 51 
the development and severity of co-infected wounds, from which Staphylococcus 52 
aureus and Pseudomonas aeruginosa are most commonly isolated (Serra et al., 53 
2015).  54 
An extensive body of evidence exists describing the relationship between S. 55 
aureus and P. aeruginosa using cystic fibrosis (CF) lung infection models (Baldan et 56 
al., 2014; Filkins et al., 2015; Maliniak et al., 2016). The lungs of children with CF are 57 
readily colonised by S. aureus during the early years of life, with colonisation by P. 58 
aeruginosa during mid to late teenage years.  Colonisation with S. aureus is 59 
associated with a higher propensity for secondary colonisation with P. aeruginosa, 60 
and once present the latter rapidly establishes and eventually predominates (Ahlgren 61 
et al., 2015; Limoli et al., 2016).  Co-infection with P. aeruginosa and S. aureus 62 
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ultimately results in a poor clinical outcome for the patient correlated with increased 63 
inflammatory markers. 64 
Less is understood about the relationship between S. aureus and P. 65 
aeruginosa in the chronic infected wound.  Chronic wounds are often co-colonised 66 
by S. aureus and P. aeruginosa, and once contaminated with P. aeruginosa the 67 
infected wound becomes highly recalcitrant to treatment (Serra et al, 2015). Biopsies 68 
of established chronic infected wounds have indicated that S. aureus and P. 69 
aeruginosa exist apart in distinct, separate niches with P. aeruginosa found within 70 
the deeper tissues and S. aureus at the surface of the wound (Fazli et al., 2009).  71 
Hypotheses currently describing co-colonised wounds therefore reject the idea that 72 
they are truly polymicrobial based on this pattern of colonisation (Woods et al., 2012; 73 
Phalak et al., 2016). 74 
Ecological theories of competitive exclusion and the niche concept support 75 
current observations of S. aureus and P. aeruginosa in chronic infected wounds 76 
(Davies, 2006).  These principles state that two-species competing for the same 77 
resource cannot stably co-exist if other ecological factors are constant.  78 
Consequently, one of the two competitors will become dominant and drive the other 79 
either to extinction or another ecological niche.  However, this is rarely observed in 80 
nature, where multiple species co-exist in a single environment.  81 
We hypothesise that the niche partitioning observed in chronic wounds occurs 82 
over a long period of time, and these two pathogens initially co-exist and interact in a 83 
beneficial manner in much the same way as oral microorganisms in plaque 84 
development.  Furthermore, we suggest that inter-bacterial interactions between S. 85 
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aureus and P. aeruginosa impact upon temporal colonisation, pathogenicity, and 86 
inflammatory responses associated with infection.   87 
Therefore the objectives of this study were to assess the relative competition 88 
between S. aureus and P. aeruginosa in co-cultured biofilm, and to determine 89 
whether co-culture resulted in synergy of growth and virulence concurrent with 90 
enhanced damage, diminished immune response and impaired repair of a human 91 
keratinocyte cell line.  92 
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Materials and Methods  93 
Bacterial strains  94 
Pseudomonas aeruginosa reference strain ATCC 9027 (NCIMB 8626) and 95 
Staphylococcus aureus NCTC 13142 (EMRSA-15) were used throughout the study. 96 
Both strains are associated with skin/wound infections. All strains were cultured 97 
aerobically at 37°C in nutrient broth (NB; Oxoid).  Selective media were used to 98 
recover the isolated from co-culture experiments, these were Pseudomonas 99 
Selective Agar (Sigma Aldrich, UK) and Baird Parker Agar (Sigma Aldrich, UK). 100 
  101 
Preparation of bacterial extracts  102 
Biofilms of S. aureus and P. aeruginosa were cultured in 5ml NB in sterile plastic 103 
Petri dishes for 24, 48 or 72h at 37oC, media was not changed during this time.  104 
Spent media (containing constituents secreted by biofilm bacteria) from these three 105 
time points was aspirated, centrifuged at 9,000 g and heat treated at 60oC for 1h.  106 
Cell extracts were prepared by washing the biofilm three times with phosphate 107 
buffered saline (PBS; Oxoid)  scraping biofilm cells from the Petri dish using a cell 108 
scraper and re-suspending them in 1ml sterile PBS prior to heat treatment as 109 
described above.  Secreted and cell extracts were stored at -20oC.  110 
  111 
Static biofilm model   112 
 113 
Co-cultured biofilms were prepared by culturing planktonic P. aeruginosa and S. 114 
aureus (separately) aerobically for 16h in NB at 37°C, which were subsequently 115 
harvested by centrifugation at 3,000 g, at 4°C for 5 minutes. Bacterial cell pellets 116 
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were re-suspended in 1ml of PBS (Oxoid) and the optical density at 600nm (OD600; 117 
SPECTROstarNano, BMG Labtech) of the culture was adjusted to 0.1 (± 0.05; 118 
equivalent to 1x108 cfu ml-1); 100µl total volume of bacterial cells from both cultures 119 
were mixed in a 1:1 ratio and 5µl used to inoculate wells of a 96-well microtitre plate 120 
(MTP), containing 50µl NB per well.  Following incubation at 37oC for 24, 48 or 72h, 121 
media and non-adherent cells were aspirated and the biofilm biomass was 122 
determined by staining with 0.5% (w/v) crystal violet, which was re-solubilized with 123 
7% (v/v) acetic acid and its concentration determined by its absorbance at 595nm.   124 
For analysis of the effect of bacterial extracts on biofilm formation and 125 
disruption, 10µl of either secreted or cell extract was added to developing (at time 126 
zero) biofilm or pre-cultured (24h) biofilm.  In the latter case, pre-cultured biofilm was 127 
incubated with the extract for 1h at 37oC prior to staining for biomass.   128 
For sequential biofilm culture, single species biofilms were grown as 129 
described above and following 24, 48 or 72h incubation, the second microorganism 130 
was inoculated at 1x108 CFU ml-1 and growth allowed to continue for a further 24h at 131 
37oC.  Biomass was assessed as described above.  132 
  133 
Total viable count and assessment of viability  134 
 135 
Biofilms were grown as described above. Media and planktonic cells were aspirated 136 
and the biofilms scraped off the surface of the plate using a cell scraper; 100µl of 137 
PBS was added to each well and the bacterial aggregates re-suspended by vigorous 138 
pipetting.  Cell suspensions were transferred to sterile microcentrifuge tubes, 139 
vortexed to ensure the cell suspension was homogenous and, serially diluted from 140 
10-1 to 10-7 using PBS. The Miles & Misra technique was used to determine the CFU 141 
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ml-1 and was performed in triplicate (Miles et al., 1938).  Plates were incubated at 142 
37°C for 24h.  143 
  144 
Protein binding assay 145 
 146 
To determine the adherence of co-cultured S. aureus and P. aeruginosa to 147 
immobilized fibronectin, fibrinogen and collagen (Sigma Aldrich) 1µg of each protein 148 
was used to coat the surface of a 96-well MTP; proteins were dissolved in coating 149 
buffer (20mM sodium bicarbonate buffer, pH 9.3) and wells were blocked with 1% 150 
(w/v) bovine serum albumin (BSA) to prevent non-specific binding. P. aeruginosa 151 
and S. aureus were grown and a 1:1 ratio was prepared as previously described.  152 
Bacterial cells were adhered to protein coated wells for 2h at 37°C. Following 153 
incubation, non-adherent cells were aspirated from the wells; the plate was washed 154 
with PBS and adherent cells fixed with 25% (v/v in water) formaldehyde for 30min at 155 
room temperature. Adherent bacteria were stained with 0.5% (w/v) crystal violet 156 
which was then re-solubilized and analysed as described above. The assay included 157 
a control set of wells containing only coating buffer without protein ligands to 158 
determine whether the wells of the plate were sufficiently coated. The experiments 159 
used three biological replicates and each assay was performed in triplicate.   160 
Assays to determine affinity of S. aureus and P. aeruginosa for bacterially-161 
derived cellular extracts utilized the same protocol except that wells were coated with 162 
50µl aliquots of extract diluted in an equal volume of coating buffer.  Blocking assays 163 
were carried out as described above, however the single species biofilm was 164 
blocked by the addition of an anti-staphylococcal antibody (1:200 in PBS; 165 
ThermoScientific) for 1h at room temperature, prior to the addition of P. aeruginosa.   166 
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 Aggregation assay   167 
 168 
Bacterial suspensions and ratios were prepared as previously described, to achieve 169 
a final volume of 1ml in co-aggregation buffer (1mM Tris-HCl [pH 8], 150mM NaCl, 170 
0.1mM CaCl2.2H2O, 0.1mM MgCl2.6H2O).  Fibronectin, fibrinogen or collagen (final 171 
concentration 1 µg ml-1) were added separately to the aliquot of bacterial cells. In an 172 
untreated control, the proteins were replaced with PBS to maintain the appropriate 173 
volume and concentration. Triplicate samples were thoroughly mixed and incubated 174 
at 37°C. The OD600 was measured after 210min. The composition of aggregates was 175 
determined by TVC, using the method of Miles and Misra, previously described.  The 176 
experiments used three biological replicates and each assay was performed in 177 
triplicate.  178 
  179 
Gentamicin protection assay   180 
 181 
HaCaT (an immortalised keratinocyte cell line)cells were maintained in Dulbecco’s 182 
Modified Eagle Medium (DMEM) supplemented with 10% heat inactivated Foetal 183 
Bovine Serum (FBS) (Biosera, East Sussex, UK), 2mM glutamine and 2.5g/L 184 
glucose (all supplements were purchased from Gibco BRL, Paisley, UK). Cells were 185 
cultured at 37°C in a humidified atmosphere with 5% CO2 for optimal growth and 186 
proliferation. 187 
The gentamicin protection assay followed the method of Rasigade et al. with 188 
some modifications (Rasigade et al., 2011).  HaCaT cells were seeded at 50,000 189 
cells/well in 24-well plates and incubated at 37oC with 5% CO2 for 48h in culture 190 
medium, as described above.  Bacterial strains were cultured and 1:1 ratios 191 
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prepared as previously described (using DMEM).  HaCaT cells were washed twice 192 
with DMEM and were infected with bacterial cells at a multiplicity of infection of 193 
200:1. Cells were incubated at 37oC for 2h to allow for adhesion and internalization 194 
of bacteria, and then washed with PBS to remove any unbound bacterial cells.  For 195 
adhesion assays, cells were osmotically shocked using pure water and extensively 196 
pipetted to release all cell-associated bacteria.  For invasion assays, infected cells 197 
were incubated for a further 1h in culture medium containing 200 µg ml-1 gentamicin 198 
to kill extracellular, but not internalized, bacteria.  Cells were washed twice in PBS 199 
and treated with pure water as described above to release internalized bacteria.  For 200 
both assays bacterial cells were enumerated using selective media as described 201 
previously.  The number of adherent bacteria was calculated by subtracting the 202 
number of internalized bacteria from the total number of cell-associated bacteria. 203 
ELISA for pro-inflammatory cytokines 204 
Cell culture media was harvested from scratch assays and analysed by ELISA to 205 
determine the concentration of IL-1, IL6 and TNF-.  These included untreated 206 
(control) cells, and these treated with bacterial extracts derived from single and two-207 
species biofilms cultured for 24, 48 and 72h.  ELISA’s were carried out according to 208 
the manufacturer’s instructions (Novex ELISA Kits; ThermoFisher Scientific).  Briefly, 209 
50l of cell supernatant (or standard) was added to each well of a pre-coated 96well 210 
MTP followed by 50l of biotinylated antibody reagent and incubated at room 211 
temperature for 3h.  The plate was washed three times with wash buffer (provided by 212 
the manufacturer) and 100l of Streptavidin HRP solution added and, the plate 213 
incubated at room temperature for 30min.  The plate was washed three times and 214 
100l of developer added to each well.  After 30min 100l of stop solution was 215 
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added to each well and the absorbance recorded at 450/550nm using a 216 
SPECTROstarNano reader (BMG Labtech). 217 
In vitro scratch wound healing assays 218 
 219 
HaCaT cells were seeded at 50,000 cells/well in a 12-well plate, and grown to 90% 220 
confluence prior to beginning scratch assays. Once confluence was reached media 221 
was removed and a scratch wound made using a 10l pipette tip; each well was 222 
washed with warm PBS (37oC) and cells incubated for a further 24h in the presence 223 
and absence of secreted or cellular components derived from single or two-species 224 
biofilms (as previously described). Images were taken at 24h to observe wound 225 
closure. 226 
Statistical analysis 227 
  228 
Statistical analysis of data used ANOVA followed by Tukeys post-hoc test, using 229 
Minitab v14.  230 
  231 
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Results  232 
S. aureus predominates in early biofilm  233 
  234 
Early biofilm formation occurs via a combination of bacterial auto/co-aggregation, 235 
and attachment to a sub-stratum.  Two-species biofilms comprised of S. aureus and 236 
P. aeruginosa, cultured for 24-72h, showed a statistically significant (P<0.05) 237 
increase in the amount of accumulated biofilm (Figure 1A) when stained with crystal 238 
violet, relative to single species biofilms of S. aureus, cultured for the same amount 239 
of time (Figure 1B).  However, the biomass increases observed between P. 240 
aeruginosa mono-species and dual-species biofilm, did not equate to a statistically 241 
significant fold-change when compared to single-species biofilms of P. aeruginosa 242 
over the same period (Figure 1B).  Fold changes were calculated relative to single-243 
species biofilms for each bacterium.   Analysis of the composition of two-species 244 
biofilm by CFU (using selective media as indicated in materials and methods) and 245 
subsequent calculation of competitive relative index, indicated that S. aureus 246 
predominated at each time point with higher competitive relative indices than P. 247 
aeruginosa (Figure 1C).  Competitive relative indices are derived from CFU and 248 
therefore higher competitive indices signify higher numbers of bacteria.  This 249 
suggests that it is advantageous for S. aureus to be part of a two-species biofilm in 250 
terms of synergistic growth. 251 
Early biofilm development for both S. aureus and P. aeruginosa relies on the 252 
formation of bacterial aggregates in suspension, which subsequently attach to a solid 253 
substratum (Birkenhauer et al., 2014).  Relative to auto-aggregation of each 254 
bacterium alone, co-aggregation of both bacteria together in suspension, led to 255 
reduced total aggregation after 210 min, relative to S. aureus  alone (auto-256 
aggregated), but was not statistically different compared to P. aeruginosa  alone 257 
 13 
(auto-aggregated) over the same time period (Figure 2A).   By comparing the extent 258 
of co-aggregation to auto-aggradation, for each bacterium it was apparent that co-259 
aggregation negatively impacted on S. aureus (i.e. the propensity to aggregate was 260 
less), but positively impacted on the propensity for P. aeruginosa to aggregate (i.e. 261 
P. aeruginosa aggregated more readily) (Figure 2A).  Competitive relative indices 262 
derived from TVC analysis of bacterial aggregates indicated that despite the reduced 263 
aggregation observed for S. aureus when co-aggregated with P. aeruginosa, S. 264 
aureus comprised the largest proportion of the bacterial aggregates (Figure 2B).  265 
Collectively these data indicate that during the early stages of biofilm 266 
development, S. aureus has a competitive advantage over P. aeruginosa in terms of 267 
aggregation, attachment and growth, but also promotes increased aggregation of P. 268 
aeruginosa.   This could be advantageous since the latter has fewer known surface 269 
adhesins and attachment to S. aureus could provide a means of integrating into the 270 
competitive environment of the early biofilm (Prince, 1992; Clarke & Foster, 2006).  271 
 272 
S. aureus early biofilm influences the attachment and maintenance of P. aeruginosa 273 
biofilm 274 
Clinical analysis of wound infection shows a typical “Gram-negative shift” over time, 275 
(Altoparlak et al., 2004; Dalton et al., 2011; Guggenheim et al., 2011; Pastar et al., 276 
2013). We investigated whether Gram positive S. aureus, through provision of a 277 
conditioning layer, promoted this shift by enhancing attachment of P. aeruginosa, as 278 
is observed for other human biofilms (Kolenbrander et al., 2010).  Using mono-279 
species biofilm of each respective bacterium as a base-line for comparative biomass 280 
accumulation and fold-changes in biofilm mass, it was evident that biofilm of S. 281 
aureus cultured for 24, 48 and 72h, subsequently inoculated with P. aeruginosa 282 
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accumulated a significantly (P<0.05) higher mass of biofilm (Figure 3A and B) 283 
relative to biofilm of S. aureus alone.  Conversely, mono-species biofilms of P. 284 
aeruginosa inoculated with S. aureus as a secondary coloniser did not show any 285 
significant increase in biofilm mass relative to single-species biofilm of P. aeruginosa 286 
(Figure 3A and B).  Of note is the statistically significant (P<0.05) decrease in the 287 
accumulation of biofilm for 24h established biofilm of P. aeruginosa following 288 
inoculation with S. aureus and further incubation for 24h (Figure 3A and B). 289 
To ascertain whether increased biofilm formation of P. aeruginosa when 290 
inoculated onto pre-formed biofilm of S. aureus was a consequence of direct 291 
attachment to S. aureus, microtitre plates were coated with protein extracts derived 292 
from 24, 48 and 72h old biofilms of S. aureus.  This resulted in a 2-2.6-fold increase 293 
in P. aeruginosa biofilm relative to P. aeruginosa mono-species biofilm.  This effect 294 
was not observed when the S. aureus proteins coating the MTP were blocked with 295 
an anti-staphylococcal antibody (Figure 3C), and biofilm accumulation was 296 
significantly (P<0.05) reduced.  Addition of spent media aspirated from S. aureus 297 
biofilm cultured for 24, 48 and 72h, to 24, 48 and 72h old biofilm of P. aeruginosa 298 
showed a similar effect to the addition of live S. aureus to pre-formed biofilm of P. 299 
aeruginosa, in that the amount of biofilm was significantly (P<0.05) less (Figure 4A) 300 
compared to the untreated control and biofilms treated with extracts from 48 and 722 301 
biofilm.  There was a concurrent reduction in recoverable bacteria (by CFU) (Figure 302 
4B) from 24h P. aeruginosa biofilms treated with secreted extracts derived from 24h 303 
S. aureus biofilm indicating the possibility of biofilm dispersal or killing of biofilm 304 
bacteria by S. aureus.   305 
This suggests both competitive and mutual interactions between S. aureus 306 
and P. aeruginosa during early biofilm establishment whereby S. aureus directly 307 
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disrupts immature biofilm of P. aeruginosa, but once it is itself established it allows 308 
for secondary attachment of P. aeruginosa.  Furthermore, these data support clinical 309 
observations that persons who are pre-colonised with S. aureus have a higher 310 
predisposition for secondary infection with P. aeruginosa (Ahlgren et al., 2015; Limoli 311 
et al., 2016).   312 
S. aureus and P. aeruginosa do not competitively attach or adhere to human plasma 313 
proteins 314 
Human tissue proteins such as collagen and hyaluronin can influence polymicrobial 315 
biofilm development (Biyikoglu et al., 2012; Birkenhauer et al., 2014).  Co-cultured S. 316 
aureus and P. aeruginosa showed impaired adherence to immobilised fibronectin, 317 
fibrinogen and collagen, that was not statistically significant (P>0.05) (less than one-318 
fold), relative to mono-cultured bacteria (Figure 5A).  Calculated competitive relative 319 
indices based on TVCs recovered for each organism, indicated that despite less 320 
attachment of both bacteria overall, S. aureus was more adept at adhering to 321 
immobilised proteins than P. aeruginosa (Figure 5B). 322 
Soluble fibrinogen, or collagen resulted in negligible co-aggregation (Figure 323 
5C) over the time course of the experiment; soluble fibronectin did not mediate any 324 
increase or decrease in co-aggregation relative to co-aggregation in co-aggregation 325 
buffer alone over the time course of the experiment (Figure 5C; Figure 2A).  326 
Furthermore, analysis of the composition of bacterial aggregates by TVC, and 327 
calculated competitive relative indices, indicated little if any competition for 328 
attachment (Figure 5D) as similar numbers of each bacteria were recovered.   329 
Therefore, these data suggest that the early interactions between S. aureus 330 
and P. aeruginosa that precede biofilm establishment and maturation are not 331 
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dependent upon the host proteins fibronectin, fibrinogen or collagen; this contrasts 332 
with other biofilm forming organisms that thrive as polymicrobial communities within 333 
the human host, and rely on host extracellular matrix proteins for biofilm 334 
establishment (Rickard et al., 2003; Peters et al, 2012). 335 
Co-infection of human keratinocytes mediates increased bacterial invasion  336 
Given the differential capacity for attachment, aggregation and interaction using a 337 
combination of microtitre-based assay and purified human proteins, we next aimed 338 
to establish whether such interactions occurred using a human cell line to represent 339 
the skin.  Using an immortalised human keratinocyte infection model infected with 340 
either P. aeruginosa or S. aureus, or both organisms together in a ratio of 1:1, we 341 
observed a statistically significant (P<0.05) increase in the number of P. aeruginosa 342 
adhered to the cell monolayer, in co-culture than in monoculture (Figure 6A).  The 343 
number of internalised, and therefore invasive, S. aureus were significantly higher 344 
(P<0.05) in co-culture compared to mono-culture (Figure 6A).  Repeat experiments 345 
using either spent media (containing secreted constituents) or cellular constituents 346 
derived from washed biofilm were undertaken; for S. aureus these were concerned 347 
only with invasion; for P. aeruginosa these were concerned only with attachment. 348 
There were statistically significant (P<0.05) fold-increases in invasion of 349 
keratinocytes by S. aureus (calculated relative to untreated controls) in response to 350 
both secreted and cellular material derived from P. aeruginosa biofilms cultured for 351 
24, 48 and 72h.  Despite being statistically significant (P<0.05) relative to untreated 352 
controls, but there was no significant difference between culture times (6B).  This 353 
indicates that the increased invasion could be mediated by soluble or cell-bound 354 
factors.   For P. aeruginosa infected keratinocytes treated with secreted or cellular 355 
material derived rom S. aureus biofilms, there was no statistically significant fold-356 
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increase in attachment irrespective of culture time (Figure 6C). This suggests that 357 
intact or live S. aureus are likely necessary to serve as a pioneer or bridging 358 
organism when attached to human cells. 359 
Co-cultured bacteria impair the pro-inflammatory response of damaged keratinocytes 360 
Having demonstrated the interaction between S. aureus and P. aeruginosa impacted 361 
upon adhesion and invasion into human keratinocytes, we then explored the effect 362 
that this might have on the pro-inflammatory response of these cells since they are 363 
the first to encounter pathogens during skin/wound infection. Treatment of 364 
immortalised human keratinocytes with extracts derived from mono- and co-cultured 365 
biofilm indicated a general trend in support of an impaired pro-inflammatory 366 
response for co-cultured biofilm, which would in turn mediate reduced neutrophil 367 
migration (Figure 7).  Significantly, higher levels of IL-6 were evident for co-cultured 368 
biofilm compared to S. aureus mono-cultured biofilm (P<0.05) but the converse was 369 
true for mono-cultured P. aeruginosa, suggesting collectively that co-culture resulted 370 
in an intermediate response.  However, the elevated production of IL-6 compared to 371 
the untreated control (20pg ml-1 [untreated] compared to 210pg ml-1 [co-culture]) 372 
suggest that this level of IL-6 production would still favour a pro-inflammatory state, 373 
synonymous with chronic infection. 374 
 375 
 376 
Co-cultured biofilm perpetuates a non-healing state that is no more recalcitrant than 377 
mono-cultured biofilm 378 
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The pro-inflammatory response can perpetuate a state of persistent, localised 379 
damage that impairs healing and promotes the maintenance of infection.  Based on 380 
our observations of differential cytokine production in response to co-cultured biofilm, 381 
monolayers of immortalised human keratinocytes were damaged by scratching, and 382 
subsequently treated with spent supernatant or cellular material derived from mono- 383 
or co-cultured biofilm.  Application of secreted biofilm components derived from co-384 
cultured biofilm (24 and 48h) had a significant effect (P<0.05) on scratch repair 385 
compared to mono-cultured biofilm of both S. aureus and P. aeruginosa (Figure 8A).  386 
Specifically healing was impaired for a greater extent by extracts derived from co-387 
culture compared to S. aureus in mono-culture, but healing was impaired to a lesser 388 
extent for P. aeruginosa compared to mono- culture.  Reminiscent of the cytokine 389 
production profiles (Figure 7), this indicated an intermediate result for co-cultured 390 
biofilm, but repair was still impaired compared to the untreated control; this supports 391 
the model of impaired healing associated with wound chronicity.  Cell derived 392 
components had no significant effect on scratch repair suggesting that secreted 393 
factors such as toxins or pyocyanin facilitated the observed effect, rather than cell-394 
structures such as LPS or LTA.  395 
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Discussion 396 
Pre-colonisation with S. aureus is known to be a risk factor for colonisation with P. 397 
aeruginosa in patients with chronic lung infection, such as that seen in cystic fibrosis.  398 
Competition between these microorganisms within the chronic infected lung is well 399 
documented and associated with worse patient outcomes (Baldan et al., 2014; 400 
Fugere et al., 2014; Limoli et al., 2017).  Information derived from the study of 401 
chronic infected wounds lags that of chronic lung infection, but it is known that both 402 
S. aureus and P. aeruginosa can co-exist within the chronic wound environment; 403 
these microorganisms are the two species most commonly isolated from such 404 
wounds (Hotterbeekx et al., 2017). 405 
Disparate evidence has described scenarios in which these two pathogens 406 
co-exist in a co-operative or competitive manner, or alternatively that they inhabit 407 
discrete sites within the wound meaning that they are unlikely to interact (Hendricks 408 
et al., 2001; Pastar et al., 2013; DeLeon et al., 2014).  The latter hypothesis is based 409 
on the observation of these bacteria in biopsies of chronic infected wounds and the 410 
former have been reliant on in vitro and/or in vivo models (Fazli et al., 2009; 411 
Hotterbeekx et al., 2017).  We hypothesise that during the early phases of co-412 
colonisation S. aureus and P. aeruginosa interact, and the distinct colonisation 413 
pattern observed in wound biopsies occurs over a long period of time, during which 414 
competition for space and nutrients, drives the population towards separation. We 415 
suggest that during those early stages of co-colonisation, bacterial interaction might 416 
mediate heightened host-damage but that over time the pathoadapted population 417 
undergoes niche partitioning with a concurrent reduction in host damage, conducive 418 
to maintenance of a stable microbial population. 419 
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The findings presented here demonstrate that a two-species biofilm 420 
comprised of S. aureus and P. aeruginosa produces a significantly (P<0.05) and 421 
consistently greater biofilm accumulated over a period of 72h, and that within these 422 
biofilms S. aureus is most numerous as a consequence of successful competition 423 
against P. aeruginosa, evidenced by analyses of relative competitive indices.  424 
Examination of early co-aggregation events that precede biofilm establishment infers 425 
advantageous circumstance for P. aeruginosa which aggregates more effectively in 426 
the presence of S. aureus.   Despite this, bacterial aggregation was diminished 427 
overall, but S. aureus was most numerous within the aggregates.  Soluble human 428 
serum proteins did not enhance aggregation nor attachment, contrary to other 429 
studies which have demonstrated that collagen and hyaluronin at wound sites can 430 
influence early polymicrobial adhesive events (Birkenhauer et al., 2014). 431 
Contemporary biofilm research has described the important role of bacterial 432 
aggregates in biofilm formation, indicating that it is possible that biofilms are seeded 433 
wholly or in part from aggregates (Kragh et al., 2016; Melaugh et al., 2016).  This 434 
being the case our results indicate that by co-aggregating with S. aureus the 435 
likelihood of colonisation by P. aeruginosa is elevated.   436 
Further to these data, we demonstrate that when S. aureus is employed as a 437 
pioneer coloniser in biofilm growth assays it augments the attachment of P. 438 
aeruginosa.  This effect is not reciprocal, moreover S. aureus added as a secondary 439 
coloniser to biofilms of P. aeruginosa established for 24h, results in diminished 440 
overall biofilm biomass indicating that S. aureus disrupts biofilm of P. aeruginosa in 441 
some way, possibly either by dispersal or through direct bactericidal activity.  442 
Additionally, secreted components derived from biofilm of S. aureus replicated this 443 
effect suggesting that biofilm dispersal relies on a secreted factor.    S. aureus, but 444 
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not S. epidermidis, is known to produce nucleases that either prevent or disrupt 445 
biofilm growth for a number of bacterial pathogens, including P. aeruginosa (Pihl et 446 
al., 2010; Tang et al., 2011; Yang et al., 2011; Pihl et al., 2013).  Furthermore, the 447 
secreted protein SpA (staphylococcal protein A) is known to interact with P. 448 
aeruginosa to impair biofilm formation and enhance the propensity to persist 449 
(Armbruster et al., 2016); it is therefore likely that the effects we have observed are 450 
mediated by either of these two proteins.   451 
In a human cell model we demonstrate that S. aureus increases the numbers 452 
of P. aeruginosa that attach to the surface of keratinocytes.  The same effect was not 453 
observed when keratinocytes are inoculated with P. aeruginosa in a suspension 454 
containing cellular components or spent media derived from staphylococcal biofilm 455 
suggesting that whole staphylococci, attached to human keratinocytes are required 456 
for augmented adhesion of P. aeruginosa.  This synergy is reciprocal; in co-culture 457 
P. aeruginosa  results in significantly (P<0.05) larger numbers of S. aureus invading 458 
the keratinocyte cell line, an effect which is also observed when S. aureus was 459 
inoculated into the cell line in the presence of spent media or cell-derived material 460 
from P. aeruginosa  biofilm.  Synergy of virulence between S. aureus and P. 461 
aeruginosa has been previously reported but appears strain-specific with no 462 
conserved interactions described (Hendricks et al., 2001; Pastar et al., 2013; 463 
DeLeon et al., 2014; Kumar and Ting, 2015; Serra et al., 2015).  These include 464 
upregulation of hla and pva, encoding α-haemlysin and Panton-Valentine leucoidin 465 
and production of staphyloxantin, but, to our knowledge we report for the first time, 466 
an increased propensity for invasion.  Of note are the disparate consequences of 467 
interaction between S. aureus and P. aeruginosa on virulence which highlights the 468 
importance of co-adaptation between these two organisms. 469 
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Damaged or infected keratinocytes produce a number of cytokines including 470 
IL-6, IL-8 and TNF-α.  Keratinocytes respond to these cytokines by proliferating and 471 
differentiating, a secondary function of these cytokines is to promote inflammation 472 
and the recruitment of macrophage to the site of infection.  Co-infected keratinocytes 473 
showed an altered cytokine profile compared to single-species infection.  Generally, 474 
the response was heightened when compared to S. aureus alone, but dampened 475 
when compared to P. aeruginosa alone.  This intermediate response to co-infection 476 
is conducive to the maintenance of low-level tissue damage associated with 477 
chronicity, prolonged colonisation and impaired wound repair.  Scratch assay 478 
corroborated these findings and those of others, in which co-culture impaired 479 
healing.  For some secreted components this was statistically significant, but for 480 
cellular derived extract, healing was impaired to no greater extent than for mono-481 
culture.  Certainly, studies of intra-abdominal wound infection indicate that 482 
polymicrobial infection does not impair the rate of healing and recovery compared to 483 
mono-microbial infection (Shah et al., 2015).  Conversely other studies have shown 484 
that re-epithelialisation is delayed by polymicrobial infection comprising S. aureus 485 
and P. aeruginosa (Pastar et al., 2013).  During this study we were not able to 486 
establish whether the impaired healing observed was due to arrested keratinocyte 487 
proliferation or migration.   488 
Collectively, the findings of this study indicate clear interactions between S. 489 
aureus and P. aeruginosa that are both competitive and reciprocally beneficial to 490 
each organism, in terms of pathogenicity and colonisation.  Several studies have 491 
shown that these bacteria interact in polymicrobial infection resulting in differential 492 
immune response and enhanced virulence.  Indeed alginate production by P. 493 
aeruginosa has been shown to promote co-existence, and the immune protein 494 
 23 
calpropectin induced co-colonisation of the lung by these two pathogens (Wakeman 495 
et al 2016; Limoli et al., 2017).  But analysis of wound biopsies show clear 496 
segregation between the two species (Fazli et al., 2009).  Therefore within the 497 
context of the broader body of research describing both in vitro  and in vivo  498 
interaction between S. aureus  and P. aeruginosa,  we suggest that these bacteria 499 
interact early on to afford the best chance of colonisation and to augment virulence, 500 
but that once established, both facets diminish and the two bacteria separate into 501 
distinct niches.  Recent work using laser electrospray ionisation mass spectrometry 502 
has indeed shown significant co-localisation between these microorganisms in 503 
biofilm cultured for 24 hours, rather than self-segregation, which might be in part due 504 
to dynamic phenotypic changes that occur in S. aureus during early attachment to 505 
biotic and abiotic surfaces (Williams et al., 1997; William’s et al, 1999; Dean et al., 506 
2015).     507 
Our findings also support the pre-colonisation hypothesis that is well 508 
established for cystic fibrosis lung, whereby persons pre-colonised with S. aureus 509 
are pre-disposed to secondary colonisation with P. aeruginosa.  There is an 510 
emerging international consensus that most of the current guidelines on the 511 
prevention and treatment of biofilms are of limited utility in chronic wounds as 512 
bacteria are present in biofilms as aggregated communities (Hoiby et al., 2015; 513 
WHO, 2015; WUWHS, 2016).    Clinicians could prioritise patient groups who are at 514 
a higher risk of colonisation with P. aeruginosa by screening chronic wounds for S. 515 
aureus and subsequently be in a position to intervene at the earliest opportunity.  516 
Globally, diagnostic labs are equipped to routinely culture and identify S. aureus 517 
therefore such an intervention could be utilised in both developed and transitional 518 
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countries to help to manage the burden of infection disease and concurrently support 519 
antimicrobial stewardship. 520 
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